ZAI LAB LIMITED Operating Loss Carryforwards
ZAI LAB LIMITED (ZLAB) had Operating Loss Carryforwards of $2.12 billion as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Income Taxes
us-gaap:OperatingLossCarryforwards · last filed 2026-02-26
- 2025-12-31: Operating Loss Carryforwards $2.12B.
- 2024-12-31: Operating Loss Carryforwards $1.95B.
- 2023-12-31: Operating Loss Carryforwards $1.80B.
- 2022-12-31: Operating Loss Carryforwards $1.48B.
| Period end | Operating Loss Carryforwards | Operating Loss Carryforwards as first filed |
|---|---|---|
| 2025-12-31 | $2.12B 10-K · filed 2026-02-26 | |
| 2024-12-31 | $1.95B 10-K · filed 2026-02-26 | |
| 2023-12-31 | $1.80B 10-K · filed 2025-02-27 | |
| 2022-12-31 | $1.48B 10-K · filed 2024-02-27 | |
| 2021-12-31 | $1.09B 10-K · filed 2023-03-01 | $1.09B 10-K · filed 2022-03-01 |
| 2020-12-31 | $605.20M 10-K · filed 2023-03-01 | $605.23M 10-K · filed 2021-03-01 |
| 2019-12-31 | $403.46M 10-K · filed 2022-03-01 | |
| 2018-12-31 | $204.69M 10-K · filed 2021-03-01 | $204.69M 20-F · filed 2019-03-29 |
| 2017-12-31 | $72.14M 20-F · filed 2020-04-29 | $72.14M 20-F · filed 2018-04-30 |
| 2016-12-31 | $34.72M 20-F · filed 2019-03-29 | |
| 2015-12-31 | $7.97M 20-F · filed 2018-04-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |